Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1139/cjpp-2013-0168PMID 24593787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

  2015cited by this paper
• Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits

  2015cited by this paper
• Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression

  2013cited by this paper
• Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice.

  2013cited by this paper
• [Effect of treatment with selective serotonin reuptake inhibitors on lipid profile: state of the art].

  2012cited by this paper
• The Effects of Atorvastatin Therapy on Rheological Characteristics of Erythrocyte Membrane, Serum Lipid Profile and Oxidative Status in Patients with Dyslipidemia

  2012cited by this paper
• [Dyslipidemia and atherosclerosis].

  2011cited by this paper
• Effects of Suxiao Jiuxin Pill () on Oxidative Stress and Inflammatory Response in Rats with Experimental Atherosclerosis

  2011cited by this paper
• Atorvastatin inhibits collar-induced intimal thickening of rat carotid artery: effect on C-type natriuretic peptide expression.

  2011cited by this paper
• Effects of suxiao jiuxin pill (see test) on oxidative stress and inflammatory response in rats with experimental atherosclerosis.

  2011cited by this paper
• Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.

  2010cited by this paper
• The Expression and Functions of Toll-Like Receptors in Atherosclerosis

  2010cited by this paper
• Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.

  2010cited by this paper
• Evaluation of some objective parameters for Ushna and Sheeta Gunas based on pharmacological study

  2010cited by this paper
• Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment

  2009cited by this paper
• The role of oxidative stress in atherosclerosis.

  2009cited by this paper
• [Effect of felodipine on the expression of NF-kappaB in rat model of atherosclerosis].

  2009cited by this paper
• Serotonin 5-HT2A Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases

  2009cited by this paper
• Atherosclerosis and oxidative stress.

  2008cited by this paper
• Novel molecules targeting dyslipidemia and atherosclerosis.

  2008cited by this paper
• Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats.

  2008cited by this paper
• Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat Brain

  2007cited by this paper
• Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment.

  2007cited by this paper
• Arterial stiffness as a risk factor for coronary atherosclerosis

  2007cited by this paper
• Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats.

  2007cited by this paper
• Vascular adhesion molecules in atherosclerosis.

  2007cited by this paper
• Oxidative stress and atherosclerosis.

  2006cited by this paper
• Application of stereological methods for the quantification of VCAM-1 and ICAM-1 expression in early stages of rabbit atherogenesis.

  2004cited by this paper
• Inflammation in Atherosclerosis and Implications for Therapy

  2004cited by this paper
• Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

  2004cited by this paper
• Modulatory effects of HMG‐CoA reductase inhibitors in diabetic microangiopathy

  2004cited by this paper
• Escitalopram versus citalopram: the surprising role of the R-enantiomer

  2004cited by this paper
• Comparative analysis of the proteome of left ventricular heart of arteriosclerosis in rat.

  2004cited by this paper
• The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant–antioxidant system in patients with dyslipidemia

  2004cited by this paper
• Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

  2003cited by this paper
• Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide

  2003cited by this paper
• Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity.

  2003cited by this paper
• Enhanced renal cortical vascularization in experimental hypercholesterolemia.

  2002cited by this paper
• [The vulnerable plaque: a necessary concept in the management of atherothrombosis].

  2002cited by this paper
• Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat.

  2002cited by this paper
• Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study.

  2002cited by this paper
• Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments.

  2001cited by this paper
• Lipoprotein oxidation and atherosclerosis.

  2001cited by this paper
• Depression and cardiac mortality: results from a community-based longitudinal study.

  2001cited by this paper
• Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

  2001cited by this paper
• Pharmacotherapy of Dyslipidemia

  2001cited by this paper
• Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

  2001cited by this paper
• A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

  2001cited by this paper
• Are platelets the link between depression and ischemic heart disease?

  2000cited by this paper
• Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation.

  1999cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.

  1998cited by this paper
• Depression is a risk factor for coronary artery disease in men: the precursors study.

  1998cited by this paper
• Expression of the adhesion molecules ICAM, VCAM, and ELAM in the arteriosclerotic plaque.

  1996cited by this paper
• Expression of VCAM‐1 and VLA‐4 dependent T‐lymphocyte adhesion to dermal fibroblasts stimulated with proinflammatory cytokines

  1996cited by this paper
• A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1995cited by this paper
• A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1995cited by this paper
• The oxidation hypothesis of atherosclerosis.

  1994cited by this paper
• Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E.

  1993cited by this paper
• Altered vasoconstrictor responsiveness in vitamin D-induced arteriosclerotic rat aortas.

  1993cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Malondialdehyde determination as index of lipid peroxidation.

  1990cited by this paper
• Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat.

  1989cited by this paper
• Morphologic and pathogenetic aspects of coronary artery atherosclerosis in ischemic heart disease.

  1989cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• How Do Paroxetine and Citalopram Affect the Force of Contraction in Endothelially Investigated and Damaged Aortic Tissue?

  2025cites this paper
• Effects of the selective serotonin reuptake inhibitors citalopram and escitalopram on glucolipid metabolism: a systematic review

  2025cites this paper
• Studies on the Evaluation of Teratogenic Potential of SSRI (Escitalopram) on Chick Embryogenesis (Gallus gallus domesticus)

  2025cites this paper
• Biomarkers of Cardiovascular Disease and Future Directions: A Review

  2023cites this paper
• The effect of curcumin on reserpine-induced depression-like behaviour in rats.

  2023cites this paper
• A systematic review and meta-analysis on the effect of selective serotonin reuptake inhibitors on endothelial function.

  2022cites this paper
• Statins and Antidepressants: A Comprehensive Review and Clinical Outlook of the Risks and Benefits of Co-prescription (2022)

  2022cites this paper
• The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022

  2022cites this paper
• Off-Target Effects of Antidepressants on Vascular Function and Structure

  2021cites this paper
• Escitalopram Ameliorates Cardiomyopathy in Type 2 Diabetic Rats via Modulation of Receptor for Advanced Glycation End Products and Its Downstream Signaling Cascades

  2020cites this paper
• Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation

  2019cites this paper
• Comparison of Lipid Reducing Properties of Escitalopram and Citalopram: A Pilot Study on Animal Model

  2018cites this paper
• Reduction of Serum Lipid Profile by Escitalopram in Depressive Patients: A Cardio Protective Aspect of SSRI Use

  2017influential citation
• A Study of Recent Cardio-Biomarkers in Myocardial Infarction : Atherosclerosis

  2017cites this paper
• BIOMARKERS: AN IMPERATIVE ACCESSION FOR DIAGNOSIS OF A DISEASE AND DRUG DEVELOPMENT

  2017cites this paper
• Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

  2016cites this paper
• Depression and Obesity

  2016cites this paper
• Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits

  2015cites this paper
• Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

  2015cites this paper